Clinical Trial Update: Prevalence of Humoral Dysfunction in Pts With Frequent Exacerbations of COPD, and the Effect of SCIgR for Prevention [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing humoral dysfunction in patients with frequent COPD exacerbations and the effect of SCIgR in prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COPD Exacerbation
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• SCIgR

Snippet

Sponsor: Rochester General Hospital | Conditions: COPD Exacerbation Acute | Phase 2 | Status: UNKNOWN